149 related articles for article (PubMed ID: 11520807)
1. Detection of N-Ras codon 61 mutations in subpopulations of tumor cells in multiple myeloma at presentation.
Kalakonda N; Rothwell DG; Scarffe JH; Norton JD
Blood; 2001 Sep; 98(5):1555-60. PubMed ID: 11520807
[TBL] [Abstract][Full Text] [Related]
2. Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.
Liu P; Leong T; Quam L; Billadeau D; Kay NE; Greipp P; Kyle RA; Oken MM; Van Ness B
Blood; 1996 Oct; 88(7):2699-706. PubMed ID: 8839865
[TBL] [Abstract][Full Text] [Related]
3. N-ras and p53 gene mutations are very rare events in multiple myeloma.
Yasuga Y; Hirosawa S; Yamamoto K; Tomiyama J; Nagata K; Aokia N
Int J Hematol; 1995 Aug; 62(2):91-7. PubMed ID: 8590778
[TBL] [Abstract][Full Text] [Related]
4. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
5. Ras oncogene mutation in multiple myeloma.
Neri A; Murphy JP; Cro L; Ferrero D; Tarella C; Baldini L; Dalla-Favera R
J Exp Med; 1989 Nov; 170(5):1715-25. PubMed ID: 2681517
[TBL] [Abstract][Full Text] [Related]
6. Oncogenes in multiple myeloma: point mutation of N-ras.
Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP
Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133
[TBL] [Abstract][Full Text] [Related]
7. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
8. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias.
Corradini P; Ladetto M; Voena C; Palumbo A; Inghirami G; Knowles DM; Boccadoro M; Pileri A
Blood; 1993 May; 81(10):2708-13. PubMed ID: 8490179
[TBL] [Abstract][Full Text] [Related]
9. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies.
Martín P; Santón A; García-Cosío M; Bellas C
Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319
[TBL] [Abstract][Full Text] [Related]
10. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of malignant insulinoma.
Pavelic K; Hrascan R; Kapitanovic S; Vranes Z; Cabrijan T; Spaventi S; Korsic M; Krizanac S; Li YQ; Stambrook P; Gluckman JL; Pavelic ZP
Anticancer Res; 1996; 16(4A):1707-17. PubMed ID: 8712689
[TBL] [Abstract][Full Text] [Related]
12. A high frequency of N-RAS oncogene mutations in multiple myeloma.
Tanaka K; Takechi M; Asaoku H; Dohy H; Kamada N
Int J Hematol; 1992 Oct; 56(2):119-27. PubMed ID: 1421173
[TBL] [Abstract][Full Text] [Related]
13. No duplicate KRAS mutation is identified on the same allele in gastric or colorectal cancer cells with multiple KRAS mutations.
Kimura K; Nagasaka T; Hoshizima N; Sasamoto H; Notohara K; Takeda M; Kominami K; Iishii T; Tanaka N; Matsubara N
J Int Med Res; 2007; 35(4):450-7. PubMed ID: 17697521
[TBL] [Abstract][Full Text] [Related]
14. H-ras oncogene point mutations in arthritic synovium.
Roivainen A; Jalava J; Pirilä L; Yli-Jama T; Tiusanen H; Toivanen P
Arthritis Rheum; 1997 Sep; 40(9):1636-43. PubMed ID: 9324018
[TBL] [Abstract][Full Text] [Related]
15. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
Conzelmann M; Linnemann U; Berger MR
Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
[TBL] [Abstract][Full Text] [Related]
16. Allele loss and point mutation in codons 12 and 61 of the c-Ha-ras oncogene in carcinogen-transformed human breast epithelial cells.
Zhang PL; Calaf G; Russo J
Mol Carcinog; 1994 Jan; 9(1):46-56. PubMed ID: 8297485
[TBL] [Abstract][Full Text] [Related]
17. RAS gene mutations in multiple myeloma and related monoclonal gammopathies.
Matozaki S; Nakagawa T; Nakao Y; Fujita T
Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261
[TBL] [Abstract][Full Text] [Related]
18. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent mutation profile in the c-Ha-ras proto-oncogene of skin tumors in mice initiated with benzo[a]pyrene.
Wei SJ; Chang RL; Merkler KA; Gwynne M; Cui XX; Murthy B; Huang MT; Xie JG; Lu YP; Lou YR; Jerina DM; Conney AH
Carcinogenesis; 1999 Sep; 20(9):1689-96. PubMed ID: 10469612
[TBL] [Abstract][Full Text] [Related]
20. Discordance between K-ras mutations in bone marrow micrometastases and the primary tumor in colorectal cancer.
Tórtola S; Steinert R; Hantschick M; Peinado MA; Gastinger I; Stosiek P; Lippert H; Schlegel W; Reymond MA
J Clin Oncol; 2001 Jun; 19(11):2837-43. PubMed ID: 11387355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
